Donye Dominguez

Immunology and Microbiology · Life Sciences

13h-index897citations32works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(13), Immune Cell Function and Interaction(10), CAR-T cell therapy research(8), IL-33, ST2, and ILC Pathways(8), RNA Interference and Gene Delivery(7)

Publications32 total

Data from Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
2023Open Access
Supplementary Figures 1-7 from Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
2023Open Access
Data from Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
2023Open Access
Supplementary Figures 1-7 from Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
2023Open Access
Disrupting the Interplay between Programmed Cell Death Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids in Treating Cancer
ACS Central Science·2022· 17 citedOpen Access
Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy
Frontiers in Immunology·2020· 32 citedOpen Access
OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
Journal of Clinical Investigation·2020· 79 citedOpen Access
RNA‐Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
Small·2019· 11 citedOpen Access
Rational vaccinology with spherical nucleic acids
Proceedings of the National Academy of Sciences·2019· 121 citedOpen Access
CD73-dependent tumor resistance to agonistic anti-4-1BB therapy through TGF-β
The Journal of Immunology·2019
Robust antitumor effects of SNA-based T cell therapy
The Journal of Immunology·2019
Enhancing Antigen Delivery Using Spherical Nucleic Acidsfor Optimal Prostate Cancer Immunotherapy
The Journal of Immunology·2019
CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy
Nature Communications·2019· 100 citedOpen Access
RNA‐Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
Small·2018· 68 citedOpen Access
Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression
The Journal of Immunology·2018· 71 citedOpen Access
[Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability
Oncology Letters·2018· 29 citedOpen Access
Novel T cell therapy using spherical nucleic acids
The Journal of Immunology·2018
Improvement of agonist cancer immunotherapy by CD73 blockade
The Journal of Immunology·2018
Type 2 innate lymphoid cells impair IL-33-mediated tumor suppression
The Journal of Immunology·2018
IL-33 in Tumor Immunity: Nothing to Sneeze At
Critical Reviews in Immunology·2018· 10 cited
page 1 of 2Next →

Frequent Co-authors

Siqi Chen(24), Jie Fan(22), Bin Zhang(20), Yi Zhang(13), Lei Qin(12), Deyu Fang(11), Alan Long(10), Timothy M. Kuzel(10), Lei Qin(9), Cong Ye(6), Alan Long(6), Andrew Lee(5), Chad A. Mirkin(5), Tyler J. Curiel(5), Natalia Chernyak(4), Bin Zhang(4), Shuya Wang(3), Kacper Skakuj(3), Zhe Geng(3), Lisa E. Cole(3)